Abbott Laboratories and AbbVie will pay $25 million to resolve allegations of kickbacks and unlawful marketing and promotion methods to induce TriCor prescriptions.
The federal government will receive $23.2 million of settlement and state Medicaid programs will receive $1.8 million, according to the U.S. Attorney’s Office for the Eastern District of Pennsylvania.
The settlement resolves allegations that between 2006 and 2008, the companies knowingly paid kickbacks to physicians to get them to prescribe TriCor to patients. Kickbacks allegedly included improper gift baskets and gift cards delivered through sales representatives.
The companies also marketed the drug for off-label uses not approved ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.